Kane Biotech Inc. announced a non-brokered private placement of up to 10,000,000 shares at a price of CAD 0.10 per share for gross proceeds of CAD 1,000,000 on March 15, 2022. The transaction is subject to receipt of all necessary approvals, including approval of the TSX Venture Exchange.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.125 CAD | -3.85% | -7.41% | +56.25% |
Apr. 18 | Transcript : Kane Biotech Inc. - Special Call | |
Apr. 15 | Kane Biotech Up 12% After Reporting Closing of STEM Animal Health Sale | MT |
1st Jan change | Capi. | |
---|---|---|
+56.25% | 12.51M | |
+1.51% | 42.59B | |
+8.57% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
-3.12% | 11.7B | |
+6.35% | 11.1B |
- Stock Market
- Equities
- KNE Stock
- News Kane Biotech Inc.
- Kane Biotech Inc. announced that it expects to receive CAD 1 million in funding